|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0014257,
umls-concept:C0028066,
umls-concept:C0030705,
umls-concept:C0034656,
umls-concept:C0332461,
umls-concept:C0542341,
umls-concept:C0599724,
umls-concept:C1280500,
umls-concept:C1522318,
umls-concept:C1522492,
umls-concept:C1956346,
umls-concept:C2603343
|
|
pubmed:issue |
13
|
|
pubmed:dateCreated |
2009-7-2
|
|
pubmed:abstractText |
Endothelial dysfunction and plaque formation are features of atherosclerosis. Inhibition of L-type calcium channels or HMG-CoA pathway improves endothelial function and reduces plaque size. Thus, we investigated in stable coronary artery disease (CAD) the effects of a calcium antagonist on coronary endothelial function and plaque size.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jul
|
|
pubmed:issn |
1522-9645
|
|
pubmed:author |
pubmed-author:BischoffKarl-OttoKO,
pubmed-author:FischerDieterD,
pubmed-author:GilRobertR,
pubmed-author:HaudeMichaelM,
pubmed-author:LüscherThomas FelixTF,
pubmed-author:MünzelThomasT,
pubmed-author:MeinertzThomasT,
pubmed-author:PieperMichaelM,
pubmed-author:RutschWolfgangW,
pubmed-author:TenderaMichaelM,
pubmed-author:VrolixMathyM,
pubmed-author:van den BrandenFrankF
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
30
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1590-7
|
|
pubmed:dateRevised |
2010-11-18
|
|
pubmed:meshHeading |
pubmed-meshheading:19474053-Acetylcholine,
pubmed-meshheading:19474053-Adult,
pubmed-meshheading:19474053-Aged,
pubmed-meshheading:19474053-Angioplasty, Balloon, Coronary,
pubmed-meshheading:19474053-Blood Pressure,
pubmed-meshheading:19474053-Calcium Channel Blockers,
pubmed-meshheading:19474053-Combined Modality Therapy,
pubmed-meshheading:19474053-Coronary Artery Disease,
pubmed-meshheading:19474053-Coronary Vessels,
pubmed-meshheading:19474053-Disease Progression,
pubmed-meshheading:19474053-Double-Blind Method,
pubmed-meshheading:19474053-Endothelium, Vascular,
pubmed-meshheading:19474053-Female,
pubmed-meshheading:19474053-Humans,
pubmed-meshheading:19474053-Lipids,
pubmed-meshheading:19474053-Male,
pubmed-meshheading:19474053-Middle Aged,
pubmed-meshheading:19474053-Nifedipine,
pubmed-meshheading:19474053-Vasodilator Agents,
pubmed-meshheading:19474053-Vasomotor System
|
|
pubmed:year |
2009
|
|
pubmed:articleTitle |
A randomized placebo-controlled study on the effect of nifedipine on coronary endothelial function and plaque formation in patients with coronary artery disease: the ENCORE II study.
|
|
pubmed:affiliation |
Department of Cardiology, Universitätsspital, Ramistrassee 100, CH-8091 Zürich, Switzerland. cardiotfl@gmx.ch
|
|
pubmed:publicationType |
Journal Article,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't,
Multicenter Study
|
